SCHEDULE: AWM Investment Co. Updates RenovoRx Stake
Beneficial Ownership Disclosure
AWM Investment Company, Inc. filed an amended Schedule 13G, disclosing its beneficial ownership of 2.4% of RenovoRx, Inc.'s common stock as of September 30, 2025.
Summary
- AWM Investment Company, Inc. (AWM) is the reporting person for this beneficial ownership statement.
- AWM acts as the investment adviser to Special Situations Cayman Fund, L.P., Special Situations Fund III QP, L.P., and Special Situations Life Sciences Fund, L.P.
- AWM beneficially owns an aggregate of 863,790 shares of RenovoRx, Inc. common stock.
- This ownership stake represents 2.4% of the total class of RenovoRx, Inc. common stock.
- AWM holds sole voting power and sole dispositive power over all 863,790 beneficially owned shares.
- The beneficial ownership was reported as of September 30, 2025.
Sentiment
Score: 5
Explanation: The filing is a routine disclosure of beneficial ownership and does not contain information that would indicate a positive or negative sentiment regarding the issuer's performance or prospects.
Future Outlook
NA
Industry Context
NA
Stakeholder Impact
- Shareholders gain transparency regarding the ownership structure of RenovoRx, Inc. due to the disclosure of AWM Investment Company, Inc.'s significant institutional holding.
Key Dates
| Date | Description |
|---|---|
| 09/30/2025 | Date of event which requires filing of this statement |
| 11/13/2025 | Signature date of the filing by Adam Stettner |
Keywords
RenovoRx, AWM Investment Company, Schedule 13G, beneficial ownership, common stock, institutional investor
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.